BridgeBio Pharma Inc. (BBIO) Misses Q1 EPS by 16c

BridgeBio Pharma Inc. (NASDAQ: BBIO) reported Q1 EPS of ($0.84), $0.16 worse than the analyst estimate of ($0.68). Revenue for the quarter came in at $194.5 million versus the consensus estimate of $178.16 million.

For earnings history and earnings-related data on BridgeBio Pharma Inc. (BBIO) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Qualcomm (QCOM) Is Said To Near Deal For Ai Chip Startup Modular - Bloomberg
• A. O. Smith CEO Stephen Shafer named chairman